Intelligence / Healthtech / FDA 510(k) Clearances / Life Technologies Corporation
Approvalsdevice cleared15 Oct 2026
Life Technologies Corporation
15 Oct 2026: Device cleared · Oncomine Dx Express Test. Recorded in the openFDA device 510(k) data.
- Decided
- 15 Oct 2026
- Device
- Oncomine Dx Express Test
- Specialty
- Pathology
- Country
- United States
- Location
- Frederick, MD
- Clearance type
- Traditional
- 510(k) number
- K260827
- Submitted
- 2026-03-13
What this signal means
A clearance starts commercialisation: distribution, reimbursement, software and sales hires.
- 268 added in the 30 days to 9 Nov 2026.
- Cardiovascular leads with 122 clearances, then Radiology (107).
Reach them with AOS
Find the decision makers at Life Technologies Corporation
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
Across AOS Research
Other records for Life Technologies Corporation in our registers.
12 NovLife Technologies Corporationwon a public contract ($592K) · HealthtechProcurement27 OctLife Technologies Corporationwon a public contract ($270K) · HealthtechProcurement9 SeptLife Technologies Corporationdevice change approved (PMA) · HealthtechApprovals
More in Pathology
FDA 510(k) Clearances
Source: openFDA device 510(k) data, data to 9 Nov 2026. Devices FDA found substantially equivalent and cleared for the US market. Decision dates as published by FDA. AOS shows what the public record says; it does not verify or endorse the company.